Encompass Health exec awarded 9,120 restricted shares

Encompass Health Corp senior vice president and treasurer Edmund Fay reported equity awards of company common stock.

Rhea-AI Filing Summary

Encompass Health Corp senior vice president and treasurer Edmund Fay reported equity awards of company common stock. On February 18, 2026, he acquired 7,690 shares of restricted stock at $0.00 per share as a grant or award. On February 19, 2026, he acquired an additional 1,430 restricted shares at $0.00 per share.

The filing notes that 1,430 shares were issued upon satisfaction of performance criteria from a performance share unit award granted on February 23, 2023. The 7,690-share transaction is described as an annual restricted stock award under the corporation's 2025 Omnibus Performance Incentive Plan. After these transactions, Fay directly owned over one hundred thousand Encompass Health common shares.

Insider Trade Summary

Grant/Award: 9,120 shares

Grant/Award 2 txns

Insider Fay Edmund

Role Sr. Vice Pres. and Treasurer

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	1,430	$0.00	$0.00
Grant/Award	Encompass Health Common Stock	7,690	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 105,609 shares (Direct)

Footnotes (2)

1. F1. This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.
2. F2. Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Edmund Fay report at Encompass Health (EHC)?

Edmund Fay reported acquiring two restricted stock awards in Encompass Health common stock, totaling 9,120 shares. One grant was 7,690 shares and the other 1,430 shares, both recorded at $0.00 per share as equity compensation rather than open-market purchases.

When did Edmund Fay receive the latest restricted stock awards from Encompass Health (EHC)?

The awards were dated February 18, 2026 and February 19, 2026. On these dates, Fay received 7,690 and 1,430 restricted shares, respectively, reflecting performance-based vesting and an annual grant under Encompass Health’s incentive compensation plans.

How many Encompass Health (EHC) shares did Edmund Fay acquire in each Form 4 transaction?

Edmund Fay acquired 7,690 shares of Encompass Health common stock in one transaction and 1,430 shares in another. Both are classified as grants or awards of restricted stock, rather than market purchases, and were reported as non-derivative equity acquisitions.

What is the nature of the 1,430-share restricted stock issuance to Edmund Fay at Encompass Health (EHC)?

The 1,430-share issuance represents restricted stock delivered after performance criteria were satisfied under a performance share unit award granted on February 23, 2023. This reflects earned performance compensation converted into Encompass Health common shares for the executive.

What plan governs Edmund Fay’s 7,690-share restricted stock award from Encompass Health (EHC)?

The 7,690-share award is described as an annual grant of restricted stock under Encompass Health’s 2025 Omnibus Performance Incentive Plan. This plan provides equity-based compensation to executives, aligning part of their pay with the company’s long-term stock performance.

Did Edmund Fay pay cash for the Encompass Health (EHC) shares reported on this Form 4?

No cash payment is shown; both transactions list a price of $0.00 per share. The filing characterizes them as equity grants or awards of restricted stock, representing compensation rather than open-market stock purchases by the executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 03:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fay Edmund

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. Vice Pres. and Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/18/2026		A		7,690(1)	A	$0	104,179	D
Encompass Health Common Stock	02/19/2026		A		1,430(2)	A	$0	105,609	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.

2. Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	Patrick Darby, attorney-in-fact for Edmund Fay	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.